FI
ALBO

Fosun International’s Albireo Pharma Inc ALBO Stock Holding History

Fosun International’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-197,005
Closed -$6.26M – 310
2019
Q2 		$6.26M Hold
197,005
– – 0.41% 37
2019
Q1 		$6.27M Hold
197,005
– – 0.4% 39
2018
Q4 		$4.49M Buy
+197,005
New +$5.21M 0.27% 47

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Fosun International's ALBO Position: Q3 2019 in Review

Fosun International sold out of Albireo Pharma Inc (ALBO) in Q3 2019, closing a stake of 197,005 shares — an estimated $6.26M sold.

Fosun International first reported a position in ALBO in Q4 2018 and held it in 3 quarters. The position peaked at $6.27M in Q1 2019. 69 funds tracked by Wall St. Rank hold ALBO as of Q3 2019.

  • Fosun International reported no remaining Albireo Pharma Inc position as of Q3 2019 after selling out during the quarter.
  • Fosun International sold 197,005 Albireo Pharma Inc shares in Q3 2019, an estimated $6.26M.
  • Fosun International first reported a position in Albireo Pharma Inc in Q4 2018 and held it in 3 quarters.
  • Fosun International's Albireo Pharma Inc position peaked at $6.27M in Q1 2019.
  • 69 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.